Asian markets ended mostly higher on Monday amid renewed optimism surrounding corona virus vaccines after Biopharmaceutical giant AstraZeneca and the University of Oxford on Saturday resumed its phase-3 vaccine trials in the UK after the Medicines Health Regulatory Authority’s approval. The trial was suspended last week over safety concerns. Meanwhile, investors are looking ahead to the US Federal Reserve’s monetary policy decision scheduled for Wednesday for monetary policy outlook cues in the world’s largest economy. Japanese shares closed higher after reports that Japan's Chief Cabinet Secretary Yoshihide Suga was elected new president of the Liberal Democratic Party, succeeding outgoing Prime Minister Shinzo Abe. As Suga, a long-time loyal aide to Abe, has vowed to continue his policies, few market players expect radical changes. Further, Chinese shares finished higher with Shanghai’s STAR Market leading gains after securities regulator approved the first batch of ETFs, which are expected to draw fresh funds towards the market.
| Asian Indices | Last Trade | Change in Points | Change in % |
| Shanghai Composite | 3,278.81 | 18.46 | 0.57 |
| Hang Seng | 24,640.28 | 136.97 | 0.56 |
| Jakarta Composite | 5,161.83 | 145.12 | 2.89 |
| KLSE Composite | 1511.36 | 6.51 | 0.43 |
| Nikkei 225 | 23,559.30 | 152.81 | 0.65 |
| Straits Times | 2,482.55 | -7.54 | -0.30 |
| KOSPI Composite | 2,427.91 | 31.22 | 1.30 |
| Taiwan Weighted | 12,787.82 | 111.87 | 0.88 |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: